Tonix Pharma (TNXP) Reports Q4 Loss of $2.08/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Tonix Pharma (TNXP) Reports Q4 Loss of $2.08/Share

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Programs Update

April 17, 2017 7:00 AM EDT

First Participant Enrolled in Phase 3 HONOR Study of TNX-102 SL in Military-Related PTSD in 1Q2017

TNX-102 SL Designated a Breakthrough Therapy for PTSD by the U.S. FDA in 4Q2016

NEW YORK, April 17, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) (Tonix), a company that is developing innovative pharmaceutical products to address public health challenges, announced financial results for the fourth quarter and full year ended December 31, 2016.

Seth Lederman, M.D., president and chief executive officer of Tonix,... More